News
)
Singapore’s National Precision Medicine (NPM) programme engages Oxford Nanopore to advance understanding of the genetics of Singapore’s multi-ethnic p
- PromethION
- Structural variation
- DNA
- RNA
August 3 2024
)
Oxford Nanopore Technologies and UMC Utrecht collaborate on 1,000 human genome sequencing project
- PromethION
- Clinical research
- Direct analysis
- Metagenomics
- Long-read
- Real-time
September 30 2024
)
)
)
Oxford Nanopore at ASHG 2022: One sequencing platform for all your biology
- PromethION
- GridION
- MinION
October 19 2022
Oxford Nanopore and Genomics England announce new strategic research project to resolve undiagnosed rare disease cases
- PromethION
- Methylation
November 1 2023
Interview: Using PromethION for Cancer, Collaborations and more
- PromethION
- Interview
- Human genomics
- Cancer research
- Methylation
- Structural variation
June 25 2021
Interview: The PromethION Experts at VIB
- PromethION
- Interview
- Human genomics
- Methylation
- Structural variation
July 2 2021
Interview: Exploring complex disease in Asian populations with PromethION
- PromethION
- Interview
- Human genomics
August 6 2021
Innovations with ultra-long reads
- PromethION
- Long-read
- Methylation
- London Calling
- Structural variation
- Phasing
June 18 2021
Blog: Resolving structural variants causing antithrombin deficiency
- PromethION
- Human genomics
- Clinical research
- Structural variation
- Variant calling
- Long-read
September 14 2020
Blog: cuteSV - a powerful tool to uncover the full spectrum of genomic structural variants
- PromethION
- Structural variation
- DNA
- gDNA
- Whole genome
- Long-read
October 19 2020
)
Al Jalila Children’s Hospital advances rare disease identification through Oxford Nanopore sequencing, a new study shows | Oxford Nanopore Technologies
- PromethION
- Whole genome
- Clinical research
- Long-read
November 14 2024